Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorder of Endocrine Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07683221
What this trial is testing

SBRT Followed by Ipilimumab N01, Sintilimab, Nab-Paclitaxel and Gemcitabine for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Shandong Cancer Hospital and Institute 47
Not applicableUnknownNCT02292914
What this trial is testing

Prospective Analysis of Robot-Assisted Surgery

Who this might be right for
Esophageal CancerGastric CancerPancreatic Cancer+7 more
Instituto do Cancer do Estado de São Paulo 1,120
Early research (Phase 1)Study completedNCT04925284
What this trial is testing

Study of XB002 in Subjects With Solid Tumors (JEWEL-101)

Who this might be right for
Non Small Cell Lung CancerCervical CancerSCCHN+8 more
Exelixis 269
Testing effectiveness (Phase 2)Ended earlyNCT02273752
What this trial is testing

Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerGastrinomaGlucagonoma+16 more
Emory University 2
Testing effectiveness (Phase 2)Study completedNCT00059826
What this trial is testing

Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Alliance for Clinical Trials in Oncology 89
Not applicableUnknownNCT03469726
What this trial is testing

Contrast-enhanced Diffusion-weighted MRI to Detect Liver Metastases in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Radboud University Medical Center 465
Not applicableWithdrawnNCT02309632
What this trial is testing

Pancreatic Cancer Screening of High-Risk Individuals in Arkansas

Who this might be right for
Pancreatic NeoplasmsPeutz-Jegher's SyndromeBRCA1 Gene Mutation+5 more
University of Arkansas
Not applicableUnknownNCT00906802
What this trial is testing

Benefit of Roux-en-Y (R-Y) Reconstruction After Pancreaticoduodenectomy

Who this might be right for
Pancreatic Cancer
Kochi University 40
Testing effectiveness (Phase 2)Study completedNCT02565641
What this trial is testing

Capecitabine (Xeloda) in Participants With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Hoffmann-La Roche 63
Not applicableStudy completedNCT01873066
What this trial is testing

Closing the Loop 24/7 in Adolescents With Type 1 Diabetes

Who this might be right for
Diabetes MellitusDiabetes Mellitus, Type 1Glucose Metabolism Disorders+1 more
University of Cambridge 24
Not applicableStudy completedNCT01401751
What this trial is testing

Feasibility Study Assessing The Ability Of An Insulin Pump-Controlling Algorithm To Minimize Hypoglycemia And Hyperglycemia In Patients With Type 1 Diabetes In A Clinical Research Setting

Who this might be right for
Type 1 Diabetes Mellitus
Animas Corporation 13
Early research (Phase 1)Study completedNCT00462553
What this trial is testing

Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid Tumors

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage III Pancreatic Cancer+2 more
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Looking for participantsNCT06710756
What this trial is testing

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Who this might be right for
Pancreatic Ductal AdenocarcinomaGastric CancerEsophageal Cancer+5 more
Perspective Therapeutics 112
Testing effectiveness (Phase 2)Looking for participantsNCT06472388
What this trial is testing

Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorsProgressionNeuroendocrine Tumor Grade 1+4 more
AC Camargo Cancer Center 100
Not applicableWithdrawnNCT03598283
What this trial is testing

Liver, Pancreas and Thyroid Function in Burn Patients

Who this might be right for
BurnsLiver FibrosesPancreas Disease+1 more
The University of Texas Medical Branch, Galveston
Large-scale testing (Phase 3)Not Yet RecruitingNCT07803783
What this trial is testing

Compare the Efficacy and Safety of YL201 With Standard Chemotherapy in Patients With Metastatic Pancreatic Cancer After Failure of Gemcitabine-Based Systemic Chemotherapy

Who this might be right for
Metastatic Pancreatic CancerPancreatic Ductal Adenocarcinoma (PDAC)
MediLink Therapeutics (Suzhou) Co., Ltd. 320
Testing effectiveness (Phase 2)Study completedNCT01821729
What this trial is testing

Radiation w/FOLFIRINOX-Losartan for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Massachusetts General Hospital 50
Large-scale testing (Phase 3)Study completedNCT01827553
What this trial is testing

Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy

Who this might be right for
Pancreatic Cancer
University of Erlangen-Nürnberg Medical School 830
Early research (Phase 1)Study completedNCT00214786
What this trial is testing

Pancreatic Islet Cell Transplantation

Who this might be right for
Type 1 Diabetes
Baylor Research Institute 4
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04901741
What this trial is testing

Olaptesed With Pembrolizumab and Nanoliposomal Irinotecan or Gemcitabine/Nab-Paclitaxel in MSS Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
TME Pharma AG 60
Next Page